Results 181 to 190 of about 52,798 (213)

Validation of an Automated Fluorescence‐ and Image‐Based Viable Cell Counting Method for Fecal Microbiota Transplantation Drug Products

Biotechnology Journal, Volume 21, Issue 6, June 2026.
Graphical Abstract and Lay Summary This study presents the first systematic development and analytical validation of an automated fluorescence‐ and image‐based viable‐cell counting method for fecal microbiota transplantation (FMT) drug products in accordance with ICH Q2(R2).
Timon Lang, Fedja Farowski, Jozef Al‐Gousous, Peter Langguth, Maria J. G. T. Vehreschild   +4 more
wiley   +1 more source

Prevalence and related factors of irritable bowel syndrome in women with chronic pelvic pain. [PDF]

Clinics (Sao Paulo)
Neto JN, Veigas KIS, Gomes LMRS, Silva LC, Silva JCRE, Leal PDC.   +5 more
europepmc   +1 more source

Caffeine and Headache: Exploring the Multifaceted Relationship

Brain and Behavior, Volume 16, Issue 6, June 2026.
ABSTRACT Purpose To explore the multifaceted relationship between caffeine and headache disorders, focusing on its dual role as both an analgesic and a potential trigger and to summarize the mechanisms underlying its anti‐nociceptive effects. Method This narrative review synthesizes evidence from experimental, clinical, and epidemiological studies on ...
Mona Hussein, Amr Hassan, Salsabil Abo Al‐Azayem, Janu Thuraiaiyah, Henrik Winther Schytz, Anter Mothenna Abdullah Nasser, Rehab Magdy   +6 more
wiley   +1 more source

Evaluation of the effectiveness of exercise therapy for irritable bowel syndrome: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Wu J, Du S, Sun Y, Ye J, Xu Y.
europepmc   +1 more source

Fecal Microbiota Transplantation From Patients With Social Anxiety Disorder Is Associated With General Anxiety‐Like Behavior and Gut Microbiota Alterations in Mice

Brain and Behavior, Volume 16, Issue 6, June 2026.
Fecal microbiota transplantation from patients with social anxiety disorder (SAD) into mice induces anxiety‐like behaviors, accompanied by gut microbiota alterations (increased Bacteroidota, decreased butyrate producers), downregulation of microbial metabolic pathways, and reduced plasma tryptophan, suggesting a causal role of gut dysbiosis in SAD ...
Yu‐Chao Feng, Xiao‐Xuan Liu, Huan Yu, Rui Liu, Ting‐Song Pang, Hua‐Ning Wang, Zheng‐Wu Peng   +6 more
wiley   +1 more source

Lessons from irritable bowel syndrome: potential for understanding and managing post-COVID. [PDF]

Front Immunol
Stallmach A, Layer P, Katzer K, Reuken PA.   +3 more
europepmc   +1 more source

Patients' Knowledge, Attitudes, and Practices Regarding Non-pharmacological Treatments for Irritable Bowel Syndrome. [PDF]

J Neurogastroenterol Motil
Li C, Liu Q, Cao J, Xu X, He H, Huang Y, Liu X, Luo R, Chang X, Liu M.   +9 more
europepmc   +1 more source

Therapeutic potential of <i>Lachnospiraceae</i> strains in irritable bowel syndrome via differential gut-brain pathways. [PDF]

Microbiome Res Rep
Yang W, Bian S, Tan H.
europepmc   +1 more source

Characterizing Abdominal Pain and Irritable Bowel Syndrome Among Individuals With Cirrhosis: Results of a Nationwide Survey. [PDF]

Gastro Hep Adv
Deng LX, Almario CV, Lai JC, Spiegel BMR, Rubin JB.   +4 more
europepmc   +1 more source